Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


05.08.2019

1 Acta Neurol Scand
1 Ann Neurol
1 Brain
1 Curr Opin Immunol
1 Diabetes
6 Intern Med
1 J Immunol
3 J Neuroimmunol
2 J Neurol
1 J Rheumatol
2 Lancet Neurol
11 Mult Scler
2 N Engl J Med
3 Neurology
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. FERRARO D, Guicciardi C, De Biasi S, Pinti M, et al
    Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients.
    Acta Neurol Scand. 2019 Jul 27. doi: 10.1111/ane.13152.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. JENDE JME, Groener JB, Oikonomou D, Heiland S, et al
    Diabetic neuropathy differs between type 1 and type 2 diabetes Insights from magnetic resonance neurography.
    Ann Neurol. 2018 Feb 14. doi: 10.1002/ana.25182.
    PubMed     Text format     Abstract available


    Brain

  3. FEINSTEIN A, Meza C, Stefan C, Staines RW, et al
    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Brain. 2019 Jul 30. pii: 5541023. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Opin Immunol

  4. SETH A, Craft J
    Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.
    Curr Opin Immunol. 2019;61:1-9.
    PubMed     Text format     Abstract available


    Diabetes

  5. BADILLO FG, Tegou FZ, Abreu MM, Masina R, et al
    CCL21 Expression in beta-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice.
    Diabetes. 2019 Aug 1. pii: db19-0239. doi: 10.2337/db19-0239.
    PubMed     Text format     Abstract available


    Intern Med

  6. MATSUO K, Koga M, Oishi M, Kawai M, et al
    Cognitive Impairment Caused by Isolated Adrenocorticotropic Hormone Deficiency without Other Hypo-adrenalism Signs - Autoimmune Encephalopathy Mimics.
    Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3234.
    PubMed     Text format     Abstract available

  7. AKIYAMA M, Kaneko Y, Takeuchi T
    Ground Glass Opacity with Mixed Consolidation on Chest Computed Tomography Reflects the Severe Condition of Pneumocystis Pneumonia in Association with a Poor Prognosis in Patients with Connective Tissue Diseases.
    Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3182.
    PubMed     Text format     Abstract available

  8. IRIE S, Anno T, Uji E, Nakamura J, et al
    Dramatic Improvement of Glycemic Control by Promptly Starting Steroid Therapy at an Early Stage of Autoimmune Pancreatitis in a Subject with Type 2 Diabetes.
    Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3198.
    PubMed     Text format     Abstract available

  9. MATSUMOTO K, Kikuchi K, Kuniyoshi N, Tsunashima H, et al
    Immunoglobulin G4-related Liver Disease Overlapping with Non-alcoholic Steatohepatitis that was Diagnosed Simultaneously with Autoimmune Pancreatitis: A Case Report and Review of the Literature.
    Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3204.
    PubMed     Text format     Abstract available

  10. KON T, Funamizu Y, Suzuki C, Sato T, et al
    A Long Interval from a Spinal Cord Lesion to a Subsequent Brain Lesion in Primary Central Nervous System Vasculitis.
    Intern Med. 2019;58:1485-1489.
    PubMed     Text format     Abstract available

  11. KASAHARA H, Sato M, Nagamine S, Makioka K, et al
    Temporal Changes on (123)I-Iomazenil and Cerebral Blood Flow Single-photon Emission Computed Tomography in a Patient with Anti-N-methyl-D-aspartate Receptor Encephalitis.
    Intern Med. 2019;58:1501-1505.
    PubMed     Text format     Abstract available


    J Immunol

  12. JAMES EA, Gillette L, Durinovic-Bello I, Speake C, et al
    DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.
    J Immunol. 2018 Nov 19. pii: jimmunol.1800723. doi: 10.4049/jimmunol.1800723.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  13. NAKAMURA Y, Igaki K, Uga K, Shibata A, et al
    Pharmacological evaluation of TAK-828F, a novel orally available RORgammat inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model.
    J Neuroimmunol. 2019;335:577016.
    PubMed     Text format     Abstract available

  14. NOSADINI M, Toldo I, Tascini B, Bien CG, et al
    LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
    J Neuroimmunol. 2019;335:577008.
    PubMed     Text format     Abstract available

  15. DEL FABBRO L, de Gomes MG, Souza LC, Goes AR, et al
    Chrysin suppress immune responses and protects from experimental autoimmune encephalomyelitis in mice.
    J Neuroimmunol. 2019;335:577007.
    PubMed     Text format     Abstract available


    J Neurol

  16. RASTAS C, Sirignano D, Barner A, Bruno-Murtha LA, et al
    Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis.
    J Neurol. 2019 Jul 26. pii: 10.1007/s00415-019-09483.
    PubMed     Text format    

  17. INOJOSA H, Proschmann U, Akgun K, Ziemssen T, et al
    A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.
    J Neurol. 2019 Jul 30. pii: 10.1007/s00415-019-09489.
    PubMed     Text format     Abstract available


    J Rheumatol

  18. KISHI T, Chipman J, Evereklian M, Nghiem K, et al
    Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    J Rheumatol. 2019 Aug 1. pii: jrheum.181275. doi: 10.3899/jrheum.181275.
    PubMed     Text format     Abstract available


    Lancet Neurol

  19. GIOVANNONI G
    Do we have equipoise when it comes to how we treat active multiple sclerosis?
    Lancet Neurol. 2019 Jul 30. pii: S1474-4422(19)30227.
    PubMed     Text format    

  20. ONTANEDA D, Tallantyre E, Kalincik T, Planchon SM, et al
    Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis.
    Lancet Neurol. 2019 Jul 30. pii: S1474-4422(19)30151.
    PubMed     Text format     Abstract available


    Mult Scler

  21. PRAVATA E, Valsasina P, Gobbi C, Zecca C, et al
    Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis.
    Mult Scler. 2019 Jul 26:1352458519865989. doi: 10.1177/1352458519865989.
    PubMed     Text format     Abstract available

  22. LARSSON D, Akerfeldt T, Carlson K, Burman J, et al
    Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.
    Mult Scler. 2019 Jul 26:1352458519863983. doi: 10.1177/1352458519863983.
    PubMed     Text format     Abstract available

  23. CAMPBELL JA, Simpson S Jr, Ahmad H, Taylor BV, et al
    Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.
    Mult Scler. 2019 Jul 26:1352458519861270. doi: 10.1177/1352458519861270.
    PubMed     Text format     Abstract available

  24. SCHWEHR NA, Kuntz KM, Butler M, Enns EA, et al
    Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis.
    Mult Scler. 2019 Jul 29:1352458519866613. doi: 10.1177/1352458519866613.
    PubMed     Text format     Abstract available

  25. SOTIRCHOS ES, Filippatou A, Fitzgerald KC, Salama S, et al
    Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.
    Mult Scler. 2019 Jul 31:1352458519864928. doi: 10.1177/1352458519864928.
    PubMed     Text format     Abstract available

  26. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.
    Mult Scler. 2019 Aug 1:1352458519863764. doi: 10.1177/1352458519863764.
    PubMed     Text format     Abstract available

  27. BOVE R, Rankin K, Lin C, Zhao C, et al
    Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis.
    Mult Scler. 2019 Aug 1:1352458519865118. doi: 10.1177/1352458519865118.
    PubMed     Text format     Abstract available

  28. MCGINLEY MP, Cola PA, Fox RJ, Cohen JA, et al
    Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
    Mult Scler. 2019 Aug 1:1352458519867314. doi: 10.1177/1352458519867314.
    PubMed     Text format     Abstract available

  29. HERRANZ E, Louapre C, Treaba CA, Govindarajan ST, et al
    Profiles of cortical inflammation in multiple sclerosis by (11)C-PBR28 MR-PET and 7 Tesla imaging.
    Mult Scler. 2019 Aug 1:1352458519867320. doi: 10.1177/1352458519867320.
    PubMed     Text format     Abstract available

  30. KILLESTEIN J, van Oosten B
    Emerging safety issues in alemtuzumab-treated MS patients.
    Mult Scler. 2019;25:1206-1208.
    PubMed     Text format    

  31. SIVAKOLUNDU DK, West KL, Maruthy GB, Zuppichini M, et al
    Reduced arterial compliance along the cerebrovascular tree predicts cognitive slowing in multiple sclerosis: Evidence for a neurovascular uncoupling hypothesis.
    Mult Scler. 2019 Aug 2:1352458519866605. doi: 10.1177/1352458519866605.
    PubMed     Text format     Abstract available


    N Engl J Med

  32. CHARROW A, Vleugels RA
    Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2019;381:465.
    PubMed     Text format    

  33. LEE I, Walker JB, Nozaki K, Willett LL, et al
    Weak and Winded.
    N Engl J Med. 2019;381:76-82.
    PubMed     Text format    


    Neurology

  34. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed     Text format    

  35. HONORAT JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, et al
    Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008061.
    PubMed     Text format     Abstract available

  36. HAPFELMEIER A, Gasperi C, Donnachie E, Hemmer B, et al
    A large case-control study on vaccination as risk factor for multiple sclerosis.
    Neurology. 2019 Jul 30. pii: WNL.0000000000008012.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  37. TENGVALL K, Huang J, Hellstrom C, Kammer P, et al
    Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Proc Natl Acad Sci U S A. 2019 Aug 2. pii: 1902623116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: